Does Rallies show Form 4 insider transactions for DOC?

Yes. Rallies tracks DOC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is DOC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DOC. It does not provide personalized investment advice.

DOC (Healthpeak Properties, Inc.) Stock Analysis - Insider Trades

Healthpeak Properties, Inc. (DOC) is a publicly traded Real Estate sector company. As of May 21, 2026, DOC trades at $19.77 with a market cap of $13.44B and a P/E ratio of 109.41. DOC moved +2.05% today. Year to date, DOC is +19.95%; over the trailing twelve months it is +12.41%. Its 52-week range spans $15.70 to $23.26. Analyst consensus is buy with an average price target of $19.60. Rallies surfaces DOC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading DOC stock inside the company?

Recent DOC insider activity includes Thomas John T bought 1.45K, Brinker Scott M bought 1.49K, Brinker Scott M bought 2.93K, Brinker Scott M bought 2.87K, and Thompson Tommy G bought 5.78K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

DOC Key Metrics

Key financial metrics for DOC
Metric	Value
Price	$19.77
Market Cap	$13.44B
P/E Ratio	109.41
EPS	$0.18
Dividend Yield	0.10%
52-Week High	$23.26
52-Week Low	$15.70
Volume	209
Avg Volume	0
Revenue (TTM)	$543.46M
Net Income	$43.77M
Gross Margin	0.00%

Recent DOC Insider Trades

Thomas John T bought 1.45K (~$24.73K) on Aug 6, 2025.
Brinker Scott M bought 1.49K (~$25.08K) on Aug 4, 2025.
Brinker Scott M bought 2.93K (~$49.99K) on Jul 31, 2025.
Brinker Scott M bought 2.87K (~$49.99K) on Jul 28, 2025.
Thompson Tommy G bought 5.78K (~$99.77K) on May 28, 2025.

Latest DOC News

Healthpeak Properties rallies after Q1 results, raised 2026 FFO guidance and Janus Living IPO — May 6, 2026
Healthpeak (DOC) slides 3% as lab-market worries resurface ahead of Q1 report — Apr 21, 2026
Healthpeak jumps as new $400 million term loan boosts liquidity ahead of Janus Living IPO — Mar 30, 2026
Robust Jobs Gain Pushes Fed Cuts to Late 2026; Physicians Realty Trust Yields Over 7% — Feb 11, 2026
Healthpeak Q4 FFO Rises to $0.47; Same-Store Cash NOI Growth Noted — Feb 6, 2026

DOC Analyst Consensus

10 analysts cover DOC: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.60.

Common questions about DOC

Who is trading DOC stock inside the company?: Recent DOC insider activity includes Thomas John T bought 1.45K, Brinker Scott M bought 1.49K, Brinker Scott M bought 2.93K, Brinker Scott M bought 2.87K, and Thompson Tommy G bought 5.78K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for DOC?: Yes. Rallies tracks DOC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is DOC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DOC. It does not provide personalized investment advice.